Re: Lack of communication

No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Lack of communication

in response to

Lack of communication

Toinv

posted on Sep 05, 2017 07:01PM

Hi Toinv,

i am also very frustrated with the lack of information or communication given on the Zen3694 trial, however I believe that there was a very sick surviving patient on the trial after 6 months on the drug that was still alive . That being the case that can't be a bad thing. We wait to hear what progress is happening with the trial

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply